Products: endoluminal-robot. Risk band: High
RobotRisk index 45.0/100 (severity- and time-weighted incidents) · ranked 3 of 25 among Medical robotics companies with incidents (173 tracked).
Analyst brief
Noah Medical shows three FDA Class II recalls of the same Galaxy System platform, spanning March 2024 through September 2025, all severity 3 and all recall-type entries. The repetition of recalls against the same device family (Galaxy System, including a controller-specific recall) indicates a recurring rather than isolated issue with that product line. Noah Medical's index of 45.0 ranks 3 of 25 companies in Medical robotics with incident history. The record is entirely regulator-driven (FDA recall classifications), with a consistent severity level and no escalation to injury or fatality entries, and the pattern points to a persistent single-product quality issue rather than a broad safety event.
Risk index
45.0/100RobotRisk index
22.1/100Median index across the 25 Medical robotics companies with incident history (173 tracked, 148 with none)
3 of 25Rank in Medical robotics (of 25 with incident history)